We just put our new website on-line, and we hope you like it! Sadly we have had to increase our prices a little, from $200 per industry standard aliquot to $250 in most cases, with a few a little higher as they are more costly to manufacture. Note that this is the first time in 20 years that we have increased our prices which were always and continue to be much lower than comparable products from essentially every other immunoreagent supplier.
We just produced another peer reviewed publication, this time in ""Spinal Cord" one of the Nature family of journals. The paper, Fusco et al. 2025, is a study of the rat spinal cord 10 days after injury using certain of our novel Degenotag™ reagents. This work supports the growing body of evidence that our reagents are uniquely capable of visualizing secondary axonal degeneration.
